Matteo Lazzeroni

Summary

Affiliation: European Institute of Oncology
Country: Italy

Publications

  1. pmc Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
    M Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Br J Cancer 108:1593-601. 2013
  2. pmc Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    BMC Cancer 12:575. 2012
  3. pmc Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Contemp Clin Trials 31:612-9. 2010
  4. pmc Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules
    Giulia Veronesi
    Division of Thoracic Surgery, European Institute of Oncology, Via Ripamonti 435, I 20141 Milan, Italy
    Cancer Prev Res (Phila) 4:34-42. 2011
  5. doi request reprint Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial
    Andrea Decensi
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Cancer Prev Res (Phila) 4:1181-9. 2011
  6. doi request reprint Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years
    Aliana Guerrieri-Gonzaga
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Oncologist 14:201-12. 2009
  7. ncbi request reprint Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users
    Andrea Decensi
    Division of Chemoprevention, European Institute of Oncology, Milan, Italy
    J Clin Oncol 25:4201-9. 2007
  8. doi request reprint The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Breast 20:S36-41. 2011
  9. ncbi request reprint Synthetic retinoid fenretinide in breast cancer chemoprevention
    Bernardo Bonanni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milano, Italy
    Expert Rev Anticancer Ther 7:423-32. 2007
  10. ncbi request reprint Retinoids and breast cancer prevention
    Bernardo Bonanni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Recent Results Cancer Res 181:77-82. 2009

Detail Information

Publications12

  1. pmc Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype
    M Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Br J Cancer 108:1593-601. 2013
    ..The post-surgical management of ductal intraepithelial neoplasia (DIN) of the breast is still a dilemma. Ki-67 labelling index (LI) has been proposed as an independent predictive and prognostic factor in early breast cancer...
  2. pmc Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    BMC Cancer 12:575. 2012
    ....
  3. pmc Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Contemp Clin Trials 31:612-9. 2010
    ..A previous trial showed a reduction in size of peripheral nodules by inhaled budesonide in subjects with bronchial dysplasia...
  4. pmc Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules
    Giulia Veronesi
    Division of Thoracic Surgery, European Institute of Oncology, Via Ripamonti 435, I 20141 Milan, Italy
    Cancer Prev Res (Phila) 4:34-42. 2011
    ..There was a trend toward regression of nonsolid and partially solid nodules after budesonide treatment. Because a subset of these nodules is more likely to represent precursors of adenocarcinoma, additional follow-up is needed...
  5. doi request reprint Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial
    Andrea Decensi
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Cancer Prev Res (Phila) 4:1181-9. 2011
    ....
  6. doi request reprint Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years
    Aliana Guerrieri-Gonzaga
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Oncologist 14:201-12. 2009
    ..We analyzed risk factors and treatment outcome in a large series of women treated at one institution...
  7. ncbi request reprint Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users
    Andrea Decensi
    Division of Chemoprevention, European Institute of Oncology, Milan, Italy
    J Clin Oncol 25:4201-9. 2007
    ..We assessed the optimal biologic dose and schedule of tamoxifen in HRT users using surrogate end point biomarkers and menopausal symptoms...
  8. doi request reprint The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Breast 20:S36-41. 2011
    ..Finally, Fenretinide, a pro-apoptotic and pro-oxidant vitamin A derivative, has shown promise in several trials and its preventive potential is being assessed in young women at very high risk for breast cancer...
  9. ncbi request reprint Synthetic retinoid fenretinide in breast cancer chemoprevention
    Bernardo Bonanni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milano, Italy
    Expert Rev Anticancer Ther 7:423-32. 2007
    ..This review will highlight the role of fenretinide in breast cancer chemoprevention...
  10. ncbi request reprint Retinoids and breast cancer prevention
    Bernardo Bonanni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Recent Results Cancer Res 181:77-82. 2009
    ..This warrants further research on fenretinide mechanisms of action and potential efficacy and provides the rationale for a phase III primary prevention trial in young women at high risk for breast cancer...
  11. ncbi request reprint Vitamin D supplementation and cancer: review of randomized controlled trials
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy
    Anticancer Agents Med Chem 13:118-25. 2013
    ..The present review summarizes the existing knowledge on vitamin D RCTs and cancer. In addition we also briefly describe the design of some ongoing trials on vitamin D supplementation and cancer...
  12. doi request reprint Breast cancer prevention by antihormones and other drugs: where do we stand?
    Matteo Lazzeroni
    Division of Cancer Prevention and Genetics, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy
    Hematol Oncol Clin North Am 27:657-72. 2013
    ..In the present review, we present an update of the chemoprevention of ER-positive breast cancer and discuss the potential role of metformin and aspirin, 2 drugs other than the specific "antihormones." ..